The future in kidney care manages more than chronic kidney disease!


This article is sponsored content brought to you by Hill’s Pet Nutrition.

Stand 35

Hill’s Prescription Diet k/d was the first therapeutic pet food in the U.S. market. It was developed by Hill’s in 1948, and has been the leading kidney food ever since, positioning nutritional therapies as a cornerstone of long-term management of CKD. Hill’s k/d Canine and k/d Feline are clinically proven to decrease episodes of uraemic crisis and to lengthen and improve the quality of life for pets with chronic kidney disease (CKD).1,2

Given the central role nutrition holds in its management, it is frustrating that pets with CKD typically experience a loss in appetite, leading to lower caloric intake and exacerbation of their disease. Hill’s has taken on this challenge and improved its k/d formulations to ensure these pets have a food that they love to eat, and which provides them with all of the nutrients they need.

Another complication is that pets are susceptible to concurrent conditions in their senior years, and older dogs and cats with CKD often also suffer from muscle wasting (cachexia), reduced mobility and cognitive decline. The new k/d formulations offer vets and pet parents solutions to these common concurrent conditions.

Firstly, the improved canine and feline formulas contain our proprietary Enhanced Appetite Trigger (E.A.T. ) Technology, which is specially tailored to renal patients to stimulate their appetite and increase their caloric intake. The new formulations also offer an enhanced amino acid profile, with higher levels of all the essential amino acids. Essential amino acids can only be provided through a pet’s diet. By supplying at least 130 per cent of dogs’ and 150 per cent of cats’ essential amino acid requirements, (according to the Association of American Feed Control Officials (AAFCO) recommended daily allowance), k/d helps ensure that even pets with advanced CKD and decreased appetite can meet the amino acid requirements necessary to prevent protein catabolism. Muscle mass is also maintained through k/d’s optimised levels of L-carnitine. L-carnitine helps the body to use fatty acids as an energy source, thus sparing muscle from being broken down into amino acids to be used for energy.

Accompanying these changes, the aesthetics of the dry and canned formula have also been improved.

To address two other common comorbidities, reduced mobility and cognitive decline, Hill’s has extended the k/d product line. The clinically proven nutrition of k/d upgrade has been combined with the nutrition of j/d into Hill’s Prescription Diet k/d + Mobility Canine and k/d + Mobility Feline. These new products feature the same high-quality protein, controlled phosphorus and sodium that have been shown to increase length and quality of life in cats and dogs with chronic kidney disease, and also have the benefits of added fatty acids to promote joint health. Antioxidants have been optimised to assist in the management of age-related cognitive decline.

For more information please contact your Hill’s Territory Manager or the Hill’s Helpline on 1800 679 932.

Visit Hill’s Pet Nutrition.

At the Hill’s Stand, you can:

  • Walk down the red carpet to the Hill’s cinema and view our selection of informative, educational, and heart-warming stories.
  • Discover the new E.A.T. Technology, which was two years in the making. Learn how E.A.T. and other upgrades to k/d make it even better than before. Find out how our new k/d plus line extensions make managing concurrent diseases of senior pets that much easier.
  • And while you’re there, what do Tetris® and amino acid profiles have in common? Have you heard about the 2017 Hill’s Global Symposium on kidney disease?

To get the answer to these and other important questions, meet our internal medicine and nutrition experts who will be spending time at the Hill’s stand during the conference. 

Dr. Becca Leung BSc, BVSc—Becca is currently at Massey University under the supervision of Dr. Nick Cave doing a residency and PhD in clinical nutrition.

Clint Yudelman BVSc (Hons) FANZCVS (Medicine)—Registered Specialist in Small Animal Medicine, Clint recently attended a symposium on renal disease in dogs and cats in the United States, and has returned with the most current and up-to-date knowledge on renal disease.

Dr Carolyn O’Brien—A registered Specialist in Feline Medicine, Carolyn is currently in the final stages of a PhD project, and is a senior tutor for the Centre of Veterinary Education’s Feline Medicine Distance Education course. She also has a strong interest in effective adult learning and professional development.


1. Jacob F, Polzin D, Osborne C, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic renal failure in dogs. J Am Vet Med. 2002;220:1163-1170.

2. Ross SJ, Osborne CA, Kirk CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc. 2006;229(6):949–957.


Please enter your comment!
Please enter your name here